1. KRAS Mutations As an Independent Prognostic Factor in Patients With Advanced Colorectal Cancer Treated With Cetuximab
   Astrid Lièvre et al, 2008, Journal of Clinical Oncology CrossRef
2. Panitumumab, a Monoclonal Anti–Epidermal Growth Factor Receptor Antibody in Colorectal Cancer: Another One or the One?
   Wells A. Messersmith et al, 2007, Clinical Cancer Research CrossRef
3. Nanobodies: COVID-19 and Future Perspectives
   Guillermo Valenzuela-Nieto et al, 2022, Frontiers in Drug Discovery CrossRef
4. EGFR Expression Is Unreliable to Decide for Cetuximab Treatment in Patients with Metastatic Colorectal Cancer: Results from “ERBITUX-OUEST”
   Jean-Philippe Metges et al, 2016, Open Journal of Internal Medicine CrossRef